Page 12 - LabMedya English - 04

/labmedya

012 HEALTH AND LABORATORY MAGAZINE

‘BIOTECHNOLOGICAL’

COOPERATION BETWEEN SABANCI

UNIVERSITY AND MERCK

The opening ceremony of opment of knowledge and can carry out training and to open this center, which
the SUNUM & MERCK Life technology, our university development studies, and will contribute to biotech-
Sciences Implementation strengthens its strength which can coordinate the nological drug research
Unit, which was established with local and international activities to create the and development, in
351 years ago as the collaborations with the in- advanced and acade- cooperation with Sabancı
SABANCI oldest pharmaceutical and dustry within the framework my-based workforce that University, one of the
prestigious and leading
are required, said that they
of the mission of ‘Creating
chemical company in the
UNIVERSITY world and which was put and Developing Together’. believe that this unit will be universities of our country,
and SU Nanotechnology
the source of leading ideas
NANOTECHNOLOGY into practice by Merck, one That we ranked the first in and inventions in the field Research and Application
Industry, Innovation and
of the leading science and
RESEARCH AND technology companies, was Infrastructure categories of health and medicine. Center (SUNUM). Turkey’s
held at Sabancı University.
in the Times Higher Edu-
visions for 2023 clearly
APPLICATION cation Universities Impact Pointing out that another aims to focus on research
CENTER AND Prof. Dr. Yusuf Leblebici, Rankings for 2019 that was important outcome of this and development in the
cooperation will be the
the Chancellor of Sabanci
published in the recent
field of health and to create
GERMAN MEDICINE University; Şehram Zayer, months is an indication of scholarship opportunities an ecosystem that creates
AND CHEMISTRY Chairman of Board of the importance we attach to doctorate students to value with the contributions
of domestic and foreign
Directors and General Di-
be determined from the
in industry collaborations”.
COMPANY MERCK, rector of Merck Turkey; Al- “SABANCI UNIVERSITY Molecular Biology, Ge- investment. We, as Merck
netics and Bioengineering
pagut Kara, the Chairman
ACTUALIZED A of the Board of Director of WILL KEEP BEING A Program, Leblebici said Turkey, are very happy to
contribute to achieve this
SIGNIFICANT R&D SUNUM; Ron Bunschoten, CENTER OF EXCELLENCE “Sabancı University will goal”.
continue to be a center of
AND ATTRACTION”
the Process Solutions
AND APPLICATION Europe Region Group excellence and attraction Touching on the impor-
UNIT IN TURKEY President of Merck; and Expressing that they are with its interdisciplinary tance of the need for
happy to continue these
trained academicians to
approach, carried out by
Fazilet Vardar Sukan, the
IN THE FIELD OF Director of SUNUM, lectur- collaborations interna- our faculty members and carry out these studies,
tionally, Leblebici said
BIOTECHNOLOGIC ers of Sabanci University, “The trust of Merck, one researchers.” Zayer said “This project will
senior managers of Merck;
contribute to our country in
PRODUCT important institutions and of the most established “WE PREDICT THAT THE many areas. In this center,
companies in the world,
CENTERS PRODUCING
researchers will be able to
organizations of public and
DEVELOPMENT. industry and many other on the infrastructure and BIOTECHNOLOGICAL work on biotechnological
from the sector participat- manpower of Sabanci Uni- DRUGS WILL INCREASE” product process devel-
ed in the ceremony. versity makes us proud. By opment, production and
combining our engineering Chairman of Board of Di- purification. The biotech-
In his speech at the cere- R&D strength with Merck, rectors and General Direc- nological product research
mony, Sabancı University we add another collab- tor of Merck, Şehram Zayer, centers in our country will
Rector Leblebici stated oration to our scientific reminded that the products be supported thanks to
that the presence of collaborations in health of Merck which celebrated the information transfer to
centers in Sabancı Universi- and medicine”. its 21st anniversary in be provided by Merck to
ty, the studies carried out Turkey in 2019 are known in obtain a GMP (good man-
and the collaborations with Leblebici who stated that Turkey since the beginning ufacturing practices). As
faculties are always among SUNUM & MERCK Life of 1900s. a result, we anticipate that
the priority issues for them. Sciences Application Unit the number of the centers
could be a unit where Pointing out that they focus producing biotechnologi-
Leblebici said “Aiming medicine and active on creating projects that cal drugs in Turkey will
to make a sustainable ingredient manufacturers add value to the country, increase. One of the most
contribution to the devel- headquartered in Turkey Zayer said “We are proud important contributions of